These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32767957)

  • 41. Development of taladegib as a sonic hedgehog signaling pathway inhibitor.
    Jin G; Sivaraman A; Lee K
    Arch Pharm Res; 2017 Dec; 40(12):1390-1393. PubMed ID: 29159582
    [No Abstract]   [Full Text] [Related]  

  • 42. Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry.
    Das D; Hong J
    Eur J Med Chem; 2019 May; 170():55-72. PubMed ID: 30878832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.
    Menear KA; Adcock C; Boulter R; Cockcroft XL; Copsey L; Cranston A; Dillon KJ; Drzewiecki J; Garman S; Gomez S; Javaid H; Kerrigan F; Knights C; Lau A; Loh VM; Matthews IT; Moore S; O'Connor MJ; Smith GC; Martin NM
    J Med Chem; 2008 Oct; 51(20):6581-91. PubMed ID: 18800822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery and optimization of phthalazinone derivatives as a new class of potent dengue virus inhibitors.
    Lu D; Liu J; Zhang Y; Liu F; Zeng L; Peng R; Yang L; Ying H; Tang W; Chen W; Zuo J; Tong X; Liu T; Hu Y
    Eur J Med Chem; 2018 Feb; 145():328-337. PubMed ID: 29335200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on antiatherosclerotic agents. Synthesis of 5-substituted derivatives of 7-ethoxycarbonyl-6,8-dimethyl-1(2H)-phthalazinone.off.
    Eguchi Y; Ishikawa M
    Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1846-8. PubMed ID: 1777938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topoisomerases as anticancer targets.
    Delgado JL; Hsieh CM; Chan NL; Hiasa H
    Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance.
    Qiu Q; Zhou J; Shi W; Kairuki M; Huang W; Qian H
    Bioorg Chem; 2019 May; 86():166-175. PubMed ID: 30710850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.
    Kathiravan MK; Kale AN; Nilewar S
    Mini Rev Med Chem; 2016; 16(15):1219-1229. PubMed ID: 27549098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. IV. 2-[2-(1-Imidazolyl)ethyl]-4-(3-pyridyl)-1(2H)-phthalazinones.
    Yamaguchi M; Koga T; Kamei K; Akima M; Maruyama N; Kuroki T; Hamana M; Ohi N
    Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1850-3. PubMed ID: 7954937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects.
    Turky A; Bayoumi AH; Ghiaty A; El-Azab AS; A-M Abdel-Aziz A; Abulkhair HS
    Bioorg Chem; 2020 Aug; 101():104019. PubMed ID: 32615465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors.
    El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Khalifa MM; Belal A; Rashed M; El-Sharkawy A; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Eissa IH
    Bioorg Chem; 2020 Oct; 103():104233. PubMed ID: 32882440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives.
    Popovici L; Amarandi RM; Mangalagiu II; Mangalagiu V; Danac R
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):230-243. PubMed ID: 30734610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies.
    Abulkhair HS; Turky A; Ghiaty A; Ahmed HEA; Bayoumi AH
    Bioorg Chem; 2020 Jul; 100():103899. PubMed ID: 32454390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antiproliferative activity of indolizinophthalazine-5,12-dione derivatives, DNA topoisomerase IB inhibitors.
    Shen DQ; Wu ZP; Wu XW; An ZY; Bu XZ; Gu LQ; Huang ZS; An LK
    Eur J Med Chem; 2010 Sep; 45(9):3938-42. PubMed ID: 20638158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
    Norman MH; Rigdon GC; Navas F; Cooper BR
    J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. III. 4-[2-(5-ethyl-2-thienyl)]-2'-[2-(1-imidazolyl)ethyl]-1(2H)- phthalazinones.
    Yamaguchi M; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1601-4. PubMed ID: 7954911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel 4-substituted-2(1H)-phthalazinone derivatives: synthesis, molecular modeling study and their effects on α-receptors.
    Khalil NA; Ahmed EM; Elshihawy HA; Zaitone SA
    Arch Pharm Res; 2013 Jun; 36(6):671-83. PubMed ID: 23543653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthetic and medicinal chemistry of phthalazines: Recent developments, opportunities and challenges.
    Zaib S; Khan I
    Bioorg Chem; 2020 Dec; 105():104425. PubMed ID: 33157344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of thiazolyl-phthalazinone acetamides as potent glucose uptake activators via high-throughput screening.
    Agrawal M; Kharkar P; Moghe S; Mahajan T; Deka V; Thakkar C; Nair A; Mehta C; Bose J; Kulkarni-Almeida A; Bhedi D; Vishwakarma RA
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5740-3. PubMed ID: 23992862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.